LB Pharmaceuticals Raises 285 Million USD in Biotech IPO, Valued at Over 300 Million
LB Pharmaceuticals has raised 285 million USD in its initial public offering in the United States, the biotechnology company has confirmed, marking the first major biotech IPO since February. The New York-based firm sold 19 million shares at 15 USD apiece, pricing the offering within its earlier indicated range of 14 to 16 USD per share.
LB Pharmaceuticals | 12/09/2025 | By Darshana
LB Pharmaceuticals Seeks 322 Million USD Valuation in Rare Biotech IPO Amid Market Slowdown
LB Pharmaceuticals, a cash-strapped drug developer, is targeting a valuation of up to 322 million USD (approximately 295 million EURO) in its upcoming New York initial public offering, which could become the first significant biotech listing in several months.
LB Pharmaceuticals | 09/09/2025 | By Darshana | 224
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy